San Francisco
Ireland-based biotech firm Elan is investing $20.2-million in the expansion and redevelopment of its four-building neurology research campus in South San Francisco. The project includes construction of a $13-million lab complex in a newly leased 66,000-sf facility. Elan will also complete the renovation of an existing 44,000-sf lab within the next three months. The expansion will concentrate Elan’s 180 Bay Area researchers in a single campus, as well as provide space for 70 additional researchers. Elan, currently developing an Alzheimer treatment drug, has invested $40-million in its Gainesville, Ga., facilities and has spent $60-million on a new plant in Ireland.
